Life Science

Animal-derived Immune Globulin Products Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

Report Format PDF, PPT, Excel
No. of Pages 104
Summary Further key aspects of the report: Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology Chapter 2: Global Industry Summary Chapter 3: Market Dynamics Chapter 4: Global Market Segmentation by region, type and End-Use Chapter 5: North America Market Segmentation by region, type and End-Use Chapter 6: Europe Market Segmentation by region, type and End-Use Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use Chapter 8: South America Market Segmentation by region, type and End-Use Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use. Chapter 10: Market Competition by Companies Chapter 11: Market forecast and environment forecast. Chapter 12: Industry Summary. The global Animal-derived Immune Globulin Products market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics. Based on the type of product, the global Animal-derived Immune Globulin Products market segmented into IVIg Liquid IVIg Powder Based on the end-use, the global Animal-derived Immune Globulin Products market classified into Immunodeficiency Autoimmune Disease Acute Infection Based on geography, the global Animal-derived Immune Globulin Products market segmented into North America [U.S., Canada, Mexico] Europe [Germany, UK, France, Italy, Rest of Europe] Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific] South America [Brazil, Argentina, Rest of Latin America] Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa] And the major players included in the report are Pfizer Rare Disease Therapeutics Instituto Bioclon Merck & Co Sanofi Protherics Genzyme Corporation End of Summary
Table of Contents 1 RESEARCH SCOPE 1.1 Research Product Definition 1.2 Research Segmentation 1.2.1 Product Type 1.2.2 Main product Type of Major Players 1.3 Demand Overview 1.4 Research Methodology 2 GLOBAL ANIMAL-DERIVED IMMUNE GLOBULIN PRODUCTS INDUSTRY 2.1 Summary about Animal-derived Immune Globulin Products Industry 2.2 Animal-derived Immune Globulin Products Market Trends 2.2.1 Animal-derived Immune Globulin Products Production & Consumption Trends 2.2.2 Animal-derived Immune Globulin Products Demand Structure Trends 2.3 Animal-derived Immune Globulin Products Cost & Price 3 MARKET DYNAMICS 3.1 Manufacturing & Purchasing Behavior in 2020 3.2 Market Development under the Impact of COVID-19 3.2.1 Drivers 3.2.2 Restraints 3.2.3 Opportunity 3.2.4 Risk 4 GLOBAL MARKET SEGMENTATION 4.1 Region Segmentation (2017 to 2021f) 4.1.1 North America (U.S., Canada and Mexico) 4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe) 4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific) 4.1.4 South America (Brazil,, Argentina, Rest of Latin America) 4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa) 4.2 Product Type Segmentation (2017 to 2021f) 4.2.1 IVIg Liquid 4.2.2 IVIg Powder 4.3 Consumption Segmentation (2017 to 2021f) 4.3.1 Immunodeficiency 4.3.2 Autoimmune Disease 4.3.3 Acute Infection 5 NORTH AMERICA MARKET SEGMENT 5.1 Region Segmentation (2017 to 2021f) 5.1.1 U.S. 5.1.2 Canada 5.1.3 Mexico 5.2 Product Type Segmentation (2017 to 2021f) 5.2.1 IVIg Liquid 5.2.2 IVIg Powder 5.3 Consumption Segmentation (2017 to 2021f) 5.3.1 Immunodeficiency 5.3.2 Autoimmune Disease 5.3.3 Acute Infection 5.4 Impact of COVID-19 in North America 6 EUROPE MARKET SEGMENTATION 6.1 Region Segmentation (2017 to 2021f) 6.1.1 Germany 6.1.2 UK 6.1.3 France 6.1.4 Italy 6.1.5 Rest of Europe 6.2 Product Type Segmentation (2017 to 2021f) 6.2.1 IVIg Liquid 6.2.2 IVIg Powder 6.3 Consumption Segmentation (2017 to 2021f) 6.3.1 Immunodeficiency 6.3.2 Autoimmune Disease 6.3.3 Acute Infection 6.4 Impact of COVID-19 in Europe 7 ASIA-PACIFIC MARKET SEGMENTATION 7.1 Region Segmentation (2017 to 2021f) 7.1.1 China 7.1.2 India 7.1.3 Japan 7.1.4 South Korea 7.1.5 Southeast Asia 7.1.6 Australia 7.1.7 Rest of Asia Pacific 7.2 Product Type Segmentation (2017 to 2021f) 7.2.1 IVIg Liquid 7.2.2 IVIg Powder 7.3 Consumption Segmentation (2017 to 2021f) 7.3.1 Immunodeficiency 7.3.2 Autoimmune Disease 7.3.3 Acute Infection 7.4 Impact of COVID-19 in Europe 8 SOUTH AMERICA MARKET SEGMENTATION 8.1 Region Segmentation (2017 to 2021f) 8.1.1 Brazil 8.1.2 Argentina 8.1.3 Rest of Latin America 8.2 Product Type Segmentation (2017 to 2021f) 8.2.1 IVIg Liquid 8.2.2 IVIg Powder 8.3 Consumption Segmentation (2017 to 2021f) 8.3.1 Immunodeficiency 8.3.2 Autoimmune Disease 8.3.3 Acute Infection 8.4 Impact of COVID-19 in Europe 9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION 9.1 Region Segmentation (2017 to 2021f) 9.1.1 GCC 9.1.2 North Africa 9.1.3 South Africa 9.1.4 Rest of Middle East and Africa 9.2 Product Type Segmentation (2017 to 2021f) 9.2.1 IVIg Liquid 9.2.2 IVIg Powder 9.3 Consumption Segmentation (2017 to 2021f) 9.3.1 Immunodeficiency 9.3.2 Autoimmune Disease 9.3.3 Acute Infection 9.4 Impact of COVID-19 in Europe 10 COMPETITION OF MAJOR PLAYERS 10.1 Brief Introduction of Major Players 10.1.1 Pfizer 10.1.2 Rare Disease Therapeutics 10.1.3 Instituto Bioclon 10.1.4 Merck & Co 10.1.5 Sanofi 10.1.6 Protherics 10.1.7 Genzyme Corporation 10.2 Animal-derived Immune Globulin Products Sales Date of Major Players (2017-2020e) 10.2.1 Pfizer 10.2.2 Rare Disease Therapeutics 10.2.3 Instituto Bioclon 10.2.4 Merck & Co 10.2.5 Sanofi 10.2.6 Protherics 10.2.7 Genzyme Corporation 10.3 Market Distribution of Major Players 10.4 Global Competition Segmentation 11 MARKET FORECAST 11.1 Forecast by Region 11.2 Forecast by Demand 11.3 Environment Forecast 11.3.1 Impact of COVID-19 11.3.2 Geopolitics Overview 11.3.3 Economic Overview of Major Countries 12 REPORT SUMMARY STATEMENT

List of Tables and Figures

List of Table Table Animal-derived Immune Globulin Products Product Type Overview Table Animal-derived Immune Globulin Products Product Type Market Share List Table Animal-derived Immune Globulin Products Product Type of Major Players Table Brief Introduction of Pfizer Table Brief Introduction of Rare Disease Therapeutics Table Brief Introduction of Instituto Bioclon Table Brief Introduction of Merck & Co Table Brief Introduction of Sanofi Table Brief Introduction of Protherics Table Brief Introduction of Genzyme Corporation Table Products & Services of Pfizer Table Products & Services of Rare Disease Therapeutics Table Products & Services of Instituto Bioclon Table Products & Services of Merck & Co Table Products & Services of Sanofi Table Products & Services of Protherics Table Products & Services of Genzyme Corporation Table Market Distribution of Major Players Table Global Major Players Sales Revenue (Million USD) 2017-2020e Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e Table Global Animal-derived Immune Globulin Products Market Forecast (Million USD) by Region 2021f-2026f Table Global Animal-derived Immune Globulin Products Market Forecast (Million USD) Share by Region 2021f-2026f Table Global Animal-derived Immune Globulin Products Market Forecast (Million USD) by Demand 2021f-2026f Table Global Animal-derived Immune Globulin Products Market Forecast (Million USD) Share by Demand 2021f-2026f List of Figure Figure Global Animal-derived Immune Globulin Products Market Size under the Impact of COVID-19, 2017-2021f (USD Million) Figure Global Animal-derived Immune Globulin Products Market by Region under the Impact of COVID-19, 2017-2021f (USD Million) Figure Global Animal-derived Immune Globulin Products Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million) Figure Global Animal-derived Immune Globulin Products Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million) Figure Global Animal-derived Immune Globulin Products Production by Region under the Impact of COVID-19, 2021-2026 (USD Million) Figure Global Animal-derived Immune Globulin Products Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million) Figure Global Animal-derived Immune Globulin Products Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million) Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure IVIg Liquid Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure IVIg Powder Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure Immunodeficiency Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure Autoimmune Disease Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure Acute Infection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure IVIg Liquid Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure IVIg Powder Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure Immunodeficiency Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure Autoimmune Disease Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure Acute Infection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure IVIg Liquid Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure IVIg Powder Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure Immunodeficiency Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure Autoimmune Disease Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure Acute Infection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure IVIg Liquid Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure IVIg Powder Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure Immunodeficiency Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure Autoimmune Disease Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure Acute Infection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure IVIg Liquid Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure IVIg Powder Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure Immunodeficiency Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure Autoimmune Disease Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure Acute Infection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure IVIg Liquid Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure IVIg Powder Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure Immunodeficiency Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure Autoimmune Disease Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure Acute Infection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure Animal-derived Immune Globulin Products Sales Revenue (Million USD) of Pfizer 2017-2020e Figure Animal-derived Immune Globulin Products Sales Revenue (Million USD) of Rare Disease Therapeutics 2017-2020e Figure Animal-derived Immune Globulin Products Sales Revenue (Million USD) of Instituto Bioclon 2017-2020e Figure Animal-derived Immune Globulin Products Sales Revenue (Million USD) of Merck & Co 2017-2020e Figure Animal-derived Immune Globulin Products Sales Revenue (Million USD) of Sanofi 2017-2020e Figure Animal-derived Immune Globulin Products Sales Revenue (Million USD) of Protherics 2017-2020e Figure Animal-derived Immune Globulin Products Sales Revenue (Million USD) of Genzyme Corporation 2017-2020e

Have questions about this research?

Speak directly with our analysts for custom insights

Contact Analyst
Starting From
$3000
$3000
$6000

Purchase Includes

PDF Report Comprehensive market analysis
PPT Presentation Executive summary slides
Excel Data Pack Market data & statistics
Analyst Support 10 hours of expert guidance
Free Updates 12 months data updates
Customization Up to 40 hours included

Have Any Questions?

Need a sample copy or have questions about pricing? Our team is here to help.

+1 646 583 1932